Cannabis Science Inc  

(Public, OTCMKTS:CBIS)   Watch this stock  
Find more results for PINK:CBIS
+0.0010 (3.33%)
Delayed:   3:38PM EDT
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.03 - 0.03
52 week 0.03 - 0.13
Open 0.03
Vol / Avg. 3.03M/5.18M
Mkt cap 36.74M
P/E     -
Div/yield     -
EPS -0.02
Shares 1.19B
Beta 2.66
Inst. own 0%

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin - -1639297.00%
Operating margin - -1551864.00%
EBITD margin - -995567.90%
Return on average assets -2967.21% -1723.57%
Return on average equity - -
Employees 5 -
CDP Score - -


Suite B #254, 6946 North Academy Blvd
United States - Map
+1-888-8890888 (Phone)


Cannabis Science, Inc. is a medical marijuana research and development company. The Company works on phytocannabinoid science targeting critical illnesses, and adheres to scientific methodologies to develop, produce and commercialize phytocannabinoid-based pharmaceutical products. It is focused on developing cannabis-based medicines, both with and without psychoactive properties, to treat disease and the symptoms of disease, as well as for general health maintenance. The Company has two subsidiaries: The Company formed two operating subsidiaries Cannabis Science BV and Cannabis Science International Holding BV. The Company has partnered with propagators and laboratories for extractions, analytical development and clinical trial implementation. It uses an inquiring approach to discover and develop cannabinoid-based therapies.

Officers and directors

Raymond C. Dabney Chief Executive Officer, Director
Age: 50
Robert Kane Chief Financial Officer, Director
Age: 39
Chad S. Johnson Esq. Chief Operating Officer, General Legal Counsel, Director
Age: 46
Richard Ogden Chief Scientific Officer
Age: 60
Mario Lap Director
Age: 63